Crowd Pleaser Cd14 Polyclonal Antibody Reactivity Human 40% Off - Today Only [zJkTuS7P]

Crowd Pleaser Cd14 Polyclonal Antibody Reactivity Human 40% Off - Today Only [zJkTuS7P]

The Crowd Pleaser Cd14 Polyclonal Antibody Reactivity Human 40% Off - Today Only [zJkTuS7P] is a highly specialized reagent designed for immunohistochemical (IHC) applications. This antibody, sourced from rabbits, offers a robust and reliable tool for researchers studying the CD14 molecule, a crucial glycoprotein expressed predominantly on monocytes and macrophages. Its human reactivity makes it an ideal choice for research involving human samples.

Key Features and Specifications

• Reactivity: Human
• Host: Rabbit
• Applications: IHC
• Isotype: IgG
• Clonality: Polyclonal
• Immunogen: Fusion protein of human CD14
• Cellular Localization: Cytoplasm, Membrane
• Concentration: 0.7 mg/mL
• Buffer: Phosphate buffered solution, pH 7.4, containing 0.05% stabilizer and 50% glycerol
• Purification Method: Antigen affinity purification
• Research Areas: Cancer, Immunology, Stem Cells
• Conjugation: Unconjugated
• Storage: Store at -20°C Valid for 12 months. Avoid freeze/thaw cycles.
• Shipping: The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.

Practical Applications and Benefits

The Crowd Pleaser Cd14 Polyclonal Antibody Reactivity Human 40% Off - Today Only [zJkTuS7P] is a valuable tool for researchers investigating the role of CD14 in various biological processes, particularly in the inflammatory response of monocytes to bacterial lipopolysaccharides (LPS). Its high specificity and affinity for human CD14 make it an essential reagent for immunohistochemical studies. With its wide range of applications in cancer, immunology, and stem cell research, this antibody can help advance your research projects in numerous ways:

• Enhance your understanding of monocyte and macrophage function in inflammatory responses.
• Investigate the role of CD14 in cancer development and progression.
• Explore the potential of CD14 as a therapeutic target in various diseases.